SCHEMBL6462824

SCHEMBL6462824

CC(CCNC(=O)O)CC(=O)NC(=O)C(CCc1ccccc1)c1nc2ccccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
MMP1 P03956 1/20 0.40
MMP3 P08254 1/20 0.40
MMP7 P09237 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PIN1 Q13526 1/20 0.39
ALDH1A1 P00352 1/20 0.38
FPR1 P21462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044833 0.90 HDAC3 (0.46) GAACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6466202 0.67 LMNA (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5281920 0.66 TAAR1 (0.50) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7362963 0.65 CYP1A2 (0.47) GAACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7433448 0.64 ALDH1A1 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2883865 0.64 NPC1 (0.53) GAACYP1A2CYP3A4CYP2D6CYP2C9
Dimethylamine SCHEMBL10893454 0.64 KMT2A (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7172022 0.64 CNR1 (0.46) GAACYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10454789 0.64 HTT (0.76) GAASMN1; SMN2HTT
SCHEMBL5626297 0.64 KMT2A (0.57) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed